BIOTECH-JOB-ALERTS.BLOGSPOT.COM HOST
Our parsers identified that a lone page on biotech-job-alerts.blogspot.com took one thousand eight hundred and fifty-four milliseconds to come up. We could not find a SSL certificate, so our crawlers consider biotech-job-alerts.blogspot.com not secure.
Internet Protocol
172.217.6.65
SERVER OS AND ENCODING
I found that this domain is operating the GSE server.PAGE TITLE
Biotech JobsDESCRIPTION
Enter your email address. Glaxo SmithKline announces start of Phase lll programme for mepolizumab in severe refractory asthma. Posted by www.biotecnika.org. 160;is a chronic condition that ultimately results in the inflammation of the air passages, making it extremely difficult to breath. Asthma can be life threatening, especially when serious cases are not effectively managed by use of an inhaler or medication. Tuesday, October 30, 2012. Posted by www.biotecnika.org. Tuesday, October 30, 2012. Tuesday,.CONTENT
This web page biotech-job-alerts.blogspot.com states the following, "Glaxo SmithKline announces start of Phase lll programme for mepolizumab in severe refractory asthma." We saw that the webpage said " 160;is a chronic condition that ultimately results in the inflammation of the air passages, making it extremely difficult to breath." It also said " Asthma can be life threatening, especially when serious cases are not effectively managed by use of an inhaler or medication. Tuesday, October 30, 2012. Tuesday, October 30, 2012."